JP2009505964A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009505964A5 JP2009505964A5 JP2008524591A JP2008524591A JP2009505964A5 JP 2009505964 A5 JP2009505964 A5 JP 2009505964A5 JP 2008524591 A JP2008524591 A JP 2008524591A JP 2008524591 A JP2008524591 A JP 2008524591A JP 2009505964 A5 JP2009505964 A5 JP 2009505964A5
- Authority
- JP
- Japan
- Prior art keywords
- fibrinogen binding
- factor
- fibrinogen
- peptide
- wound site
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0516091.6A GB0516091D0 (en) | 2005-08-04 | 2005-08-04 | Therapeutic agent |
| PCT/GB2006/002934 WO2007015107A2 (en) | 2005-08-04 | 2006-08-04 | Artificial platelets |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009505964A JP2009505964A (ja) | 2009-02-12 |
| JP2009505964A5 true JP2009505964A5 (enExample) | 2009-09-17 |
Family
ID=34984119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008524591A Pending JP2009505964A (ja) | 2005-08-04 | 2006-08-04 | 人工血小板 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20090203619A1 (enExample) |
| EP (2) | EP2335737A3 (enExample) |
| JP (1) | JP2009505964A (enExample) |
| CN (1) | CN101267843A (enExample) |
| AU (1) | AU2006274685A1 (enExample) |
| CA (1) | CA2625917A1 (enExample) |
| GB (2) | GB0516091D0 (enExample) |
| IL (1) | IL189105A0 (enExample) |
| WO (1) | WO2007015107A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0623607D0 (en) | 2006-11-27 | 2007-01-03 | Haemostatix Ltd | Tissue adhesive |
| WO2008113796A1 (en) * | 2007-03-21 | 2008-09-25 | Dsm Ip Assets B.V. | Cholesterol lowering protein hydrolysates |
| KR20100057061A (ko) * | 2007-09-11 | 2010-05-28 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 펩티드 ｍａｉｐｐｋｋｎｑｄｋ （소 카파 카세인 １０６－１１６）및／또는 ｙｇｆｑｎａ （세로르핀）의 용도 |
| US20100204107A1 (en) * | 2007-09-11 | 2010-08-12 | Dorian Bevec | Use of urodilatin as a therapeutic agent |
| GB201101740D0 (en) * | 2011-02-01 | 2011-03-16 | Haemostatix Ltd | Therapeutic agents with improved fibrinogen binding |
| WO2013021353A1 (en) * | 2011-08-11 | 2013-02-14 | Bar-Ilan University | Surface modified proteinaceous spherical particles and uses thereof |
| GB201201751D0 (en) * | 2012-02-01 | 2012-03-14 | Haemostatix Ltd | Haemostatic wound dressing |
| WO2014197816A1 (en) * | 2013-06-06 | 2014-12-11 | Massachusetts Institute Of Technology | Stimulus responsive nanocomplexes and methods of use thereof |
| KR20230007555A (ko) * | 2013-06-28 | 2023-01-12 | 바이오버라티브 테라퓨틱스 인크. | Xten을 지닌 트롬빈 절단가능한 링커 및 이의 용도 |
| EP3069141A4 (en) | 2013-11-15 | 2017-05-10 | President and Fellows of Harvard College | Methods and assays for factor viii activity |
| GB201400292D0 (en) * | 2014-01-08 | 2014-02-26 | Haemostatix Ltd | Peptide dendrimers and agents |
| EA201691111A1 (ru) | 2014-01-10 | 2017-01-30 | Байоджен Ма Инк. | Химерные белки фактора viii и их применение |
| GB201508024D0 (en) * | 2015-05-11 | 2015-06-24 | Haemostatix Ltd | Haemostatic compositions |
| CN107686506B (zh) * | 2016-08-05 | 2021-03-30 | 首都医科大学 | 华法林-4-o-乙酰-gprp,其合成,活性和应用 |
| KR20190090827A (ko) | 2016-12-02 | 2019-08-02 | 바이오버라티브 테라퓨틱스 인크. | 키메라 응고 인자를 사용해 혈우병성 관절증을 치료하는 방법 |
| CN108976285B (zh) * | 2017-05-31 | 2021-11-30 | 首都医科大学 | Gly-Pro-Arg-Pro-AA修饰的华法林,其合成,活性和应用 |
| CN108976284B (zh) * | 2017-05-31 | 2021-11-30 | 首都医科大学 | 含Gly-Pro-Arg-Pro的五肽修饰的华法林,其合成,活性和应用 |
| ES2832881T3 (es) * | 2018-04-24 | 2021-06-11 | Fibriant B V | Variantes de fibrinógeno gamma prima para su uso en el tratamiento de una infección |
| KR102914074B1 (ko) | 2018-05-18 | 2026-01-16 | 바이오버라티브 테라퓨틱스 인크. | A형 혈우병의 치료 방법 |
| CN115010784B (zh) * | 2022-05-16 | 2023-03-31 | 江南大学 | 一种ace抑制肽及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9107628D0 (en) | 1991-04-10 | 1991-05-29 | Moonbrook Limited | Preparation of diagnostic agents |
| DE69334033D1 (de) * | 1992-05-21 | 2006-07-27 | Diatide Inc | Technetium-99M markierte Peptide zur Bilderzeugung von Thrombus |
| US6184205B1 (en) * | 1994-07-22 | 2001-02-06 | University Of North Carolina At Chapel Hill | GRB2 SH3 binding peptides and methods of isolating and using same |
| ATE217344T1 (de) * | 1994-09-21 | 2002-05-15 | Cytogen Corp | Antigen bindende peptide (abtides) aus peptidbibliotheken |
| AU718956B2 (en) * | 1996-10-21 | 2000-05-04 | Quadrant Healthcare (Uk) Limited | Platelet substitutes and conjugation methods suitable for their preparation |
| US6264988B1 (en) * | 1997-06-05 | 2001-07-24 | Hemosphere, Inc. | Fibrinogen-coated microspheres |
| DK9700423U3 (da) * | 1997-11-10 | 1999-03-12 | Simatek A S | Multifunktion cip-dyse |
| US20030021777A1 (en) * | 1998-02-20 | 2003-01-30 | Roy Harris | Product comprising bound fibrinogen and thrombin for use in wound therapy or surgical repair |
| GB9827813D0 (en) * | 1998-12-17 | 1999-02-10 | Andaris Ltd | Pharmaceutical conjugates |
| US6984373B2 (en) * | 2000-12-23 | 2006-01-10 | Dyax Corp. | Fibrin binding moieties useful as imaging agents |
| GB0323378D0 (en) * | 2003-10-07 | 2003-11-05 | Univ Leicester | Therapeutic agent |
| GB0413346D0 (en) * | 2004-06-15 | 2004-07-21 | Theryte Ltd | Treating cancer |
| GB201201751D0 (en) * | 2012-02-01 | 2012-03-14 | Haemostatix Ltd | Haemostatic wound dressing |
-
2005
- 2005-08-04 GB GBGB0516091.6A patent/GB0516091D0/en not_active Ceased
-
2006
- 2006-08-04 EP EP10196237.1A patent/EP2335737A3/en not_active Withdrawn
- 2006-08-04 WO PCT/GB2006/002934 patent/WO2007015107A2/en not_active Ceased
- 2006-08-04 CN CNA2006800348757A patent/CN101267843A/zh active Pending
- 2006-08-04 GB GB0615545.1A patent/GB2429153C/en not_active Expired - Fee Related
- 2006-08-04 EP EP06765236.2A patent/EP1919508B1/en not_active Expired - Lifetime
- 2006-08-04 CA CA002625917A patent/CA2625917A1/en not_active Abandoned
- 2006-08-04 JP JP2008524591A patent/JP2009505964A/ja active Pending
- 2006-08-04 AU AU2006274685A patent/AU2006274685A1/en not_active Abandoned
- 2006-08-04 US US11/997,540 patent/US20090203619A1/en not_active Abandoned
-
2008
- 2008-01-29 IL IL189105A patent/IL189105A0/en unknown
-
2012
- 2012-02-29 US US13/408,897 patent/US20130029913A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9493513B2 (en) | Polypeptides and their use | |
| JP2010180217A5 (enExample) | ||
| JP2001511347A5 (enExample) | ||
| JP2010530238A5 (enExample) | ||
| CA2316280A1 (en) | Novel g protein-coupled receptor | |
| JP2003534013A5 (enExample) | ||
| WO2005051998A3 (en) | Antibodies binding to a c-terminal fragment of apolipoprotein e | |
| JP2002543825A5 (enExample) | ||
| JP2010533478A5 (enExample) | ||
| JP2013505287A5 (enExample) | ||
| CN102590490A (zh) | 测定凝固抑制剂的方法 | |
| JP2004512010A5 (enExample) | ||
| WO2005087811A3 (en) | Estrogen receptors and methods of use | |
| JP2008519592A5 (enExample) | ||
| JP2006503088A5 (enExample) | ||
| WO2008142664A3 (en) | Exposed thymidine kinase 1 peptides, ligands and methods employing the same | |
| CN110669109A (zh) | 一种酶联标签短肽及其应用 | |
| WO2007064844A3 (en) | Anti-viral griffithsin compounds, compositions, and methods of use | |
| JP2009525741A5 (ja) | HERV−W干渉群に属するウィルスの包膜とhASCT受容体との間の相互作用に必要なペプチド領域からなるペプチド | |
| JP2005509160A5 (enExample) | ||
| Käkönen et al. | Purification and characterization of recombinant osteocalcin fusion protein expressed inEscherichia coli | |
| WO2024123896A2 (en) | Targeting sortilin | |
| JP2010503687A5 (enExample) | ||
| CA2597545A1 (en) | Antibody for assay of adamts13 activity and method for assaying the activity | |
| DE502005004379D1 (de) | Gegen den Marburg I Polymorphismus der Faktor VII aktivierenden Protease (FSAP) gerichtete Antikörper, ihre Herstellung und Verwendung |